Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders

Advancing primary care with essential peer-reviewed research and insights into CNS disorders

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Rounds in the General Hospital

PCC
Clozapine: Its Use and Monitoring
Rounds in the General Hospital

July 30, 2024

The authors provide the latest information on clozapine use, including when your patients should receive or avoid taking it, what laboratory tests are required before and during administration, and…
Desta S. Lissanu, Chirag M. Vyas, Carol S. Lim, et al
PCC
Pharmacologic Management of TBI
Rounds in the General Hospital

July 16, 2024

Cognitive complaints, including difficulties with attention, concentration, and memory, are common in patients post-TBI; however, many medications have been studied in the treatment of cognition after TBI. Read on…
Sofia E. Matta, Christina LaCroix, Kaloyan Tanev, et al
PCC
Evaluation and Management of Treatment-Resistant Schizophrenia
Rounds in the General Hospital

July 2, 2024

If you have ever been uncertain about how to evaluate patients with a chronic psychotic illness or struggled over how best to manage treatment-resistant schizophrenia, then this case vignette…
Carol S. Lim, Abigail L. Donovan, Chirag M. Vyas, et al
PCC
Neuropsychiatric Complications of Hypervitaminosis D
Rounds in the General Hospital

June 13, 2024

A 28-year-old man presented to the emergency department with severe agitation, insomnia, weakness, constipation, and muscle jerks after nonsuicidal overdosing of vitamin D.
James K. Rustad, Adam Z. Spitz, Brandon C. Wilson, et al
PCC
Impact of Disability on Medical Care
Rounds in the General Hospital

June 6, 2024

Given that many people have disabilities, physicians should develop skills that assess the level of disability, the functional consequence of illness, and the social and physical environments of patients…
Mirza Baig, Andrew S. Chun, Ashika Bains, et al
PCC
Management of Rumination and Obsessions in Primary Care
Rounds in the General Hospital

May 30, 2024

Difficult-to-control negative repetitive thoughts can manifest as ruminations or obsessions. Appropriate early identification and intervention can positively affect the course and prevent an episode of psychiatric illness.
Sharmin Ghaznavi, Charlotte Schiewe, Theodore A. Stern

Page 10

More PCC Articles

JCP
Medication Adherence in a Transdiagnostic FEP Sample
Original Research

November 1, 2023

Thirty percent of patients with first-episode psychosis showed non-adherence to medication over a period of up to 5½ years. Treatment factors such as the type or dose of antipsychotic…
Stephanie M. London, Philip B. Cawkwell, Ann K. Shinn
JCP
Training for Lasting Trauma-Informed Change
Original Research

October 30, 2023

Two-day training in trauma-informed care (TIC) significantly improved understanding and implementation of TIC at both the individual and systemwide levels.
Alexandra R. Mangus, E. Kate Webb, Miri Bar-Halpern, et al
JCP
Long-Term Benzodiazepine Treatment: Toward Evidence-Based Practice Guidelines
Commentary

October 25, 2023

The evidence about long-term benzodiazepine use presents a confounding paradox. This commentary proposes a set of prescribing guidelines for clinicians.
Edward Silberman, Antonio E. Nardi, Vladan Starcevic, et al
JCP
Heated Yoga for Depression
Original Research

October 23, 2023

Approximately 1 heated yoga session per week for 8 weeks led to significantly greater reduction in depression symptoms than a waitlist control.
Maren B. Nyer, Lindsey B. Hopkins, Megha Nagaswami, et al
JCP
Adult Outcomes of Children With Reactive Attachment Disorder
Original Research

October 18, 2023

Adults who had reactive attachment disorder as children had high rates of psychiatric diagnoses, substance use, suicide attempts, and psychiatric hospitalizations.
Hannah K. Betcher, Tanner J. Bommersbach, Bruno A. Perossa, et al
JCP
Obsessive-Compulsive Symptoms and Psychosis Risk
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ October 16, 2023

Among youth at clinical high risk for psychosis, obsessive-compulsive symptoms had a high prevalence (50%) and were associated with a more severe clinical and functional profile.
Laura Vergara, Elena de la Serna, Gisela Sugranyes, et al
JCP
Physical Exercise and Health, 2: Benefits of Different Levels and Patterns of Activity
Clinical and Practical Psychopharmacology

October 11, 2023

This article provides guidance about exercise for adults, including how many steps per day are enough, whether bursts of activity during the day improve health, and whether “weekend warrior”…
Chittaranjan Andrade
JCP
Solriamfetol for ADHD in Adults
Original Research

October 9, 2023

Some individuals with attention-deficit/hyperactivity disorder (ADHD) may not tolerate or adequately respond to currently available treatments. This study examined the efficacy and tolerability of solriamfetol in the treatment for…
Craig B. H. Surman, Daniel M. Walsh, Nora Horick, et al
JCP
Celecoxib Augmentation of Vortioxetine for Cognition in MDD
Original Research

October 4, 2023

Anti-inflammatory augmentation of vortioxetine did not provide additional benefit in reducing cognitive symptoms of MDD.
Emma Sampson, Natalie T. Mills, Hikaru Hori, et al
JCP
Physical Exercise and Health, 1: Terminology, Guidance, Benefits, and Risks
Clinical and Practical Psychopharmacology

October 4, 2023

This article outlines current evidence and guidance for clinicians on encouraging physical activity in their patients.
Chittaranjan Andrade
JCP
Lemborexant and Daridorexant in Insomnia: NNT, NNH, and LHH
Original Research

October 2, 2023

This study examined whether differences existed between lemborexant and daridorexant in number needed to treat (NNT), number needed to harm (NNH), and likelihood to be helped or harmed (LHH)…
Leslie Citrome, Timothy R. Juday, Christie Lundwall
JCP
Dual Orexin Receptor Antagonists and Suicide Risk
Brief Report

September 27, 2023

According to the WHO pharmacovigilance database, suicidal behavior was 1.3 times more frequent than expected with dual orexin receptor antagonists and 4.7 times more frequent for Z-drugs; data on…
Francesco Salvo, Laura Palagini, Pierre A. Geoffroy

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe